High-performance liquid chromatographic procedures for the quantitative determination of paclitaxel (Taxol) in human urine
スポンサーリンク
概要
- 論文の詳細を見る
- 1995-02-17
著者
-
Koopmans F.
Dept. Of Pharmacy And Pharmacology Slotervaart Hospital The Netherlands Cancer Institute
-
Koopman F.
Department Of Pharmacy And Pharmacology Netherlands Cancer Institute/slotervaart Hospital
-
ROSING H.
Department of Pharmacy and Pharmacology, Netherlands Cancer Institute/Slotervaart Hospital
-
BEIJNEN J.
Department of Pharmacy and Pharmacology, Netherlands Cancer Institute/Slotervaart Hospital
-
HUIZING M.
Dept. of Pharmacy and Pharmacology, Slotervaart Hospital, The Netherlands Cancer Institute
-
ROSING H.
Dept. of Pharmacy and Pharmacology, Slotervaart Hospital, The Netherlands Cancer Institute
-
HUIZING M.
Department of Pharmacy, Slotervaart Hospital
-
KEUNG A.
Department of Metabolism and Pharmacokinetics
-
PINEDO H.
Dept of Medical Oncology, Free University Hospital
-
Pinedo H.
Dept Of Medical Oncology Free University Hospital
-
Rosing H.
Dept. Of Pharmacy And Pharmacology Slotervaart Hospital The Netherlands Cancer Institute
-
Rosing H.
Department Of Pharmacy And Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
-
Beijnen J.
Dept. Of Pharmacy And Pharmacology Slotervaart Hospital The Netherlands Cancer Institute
-
Beijnen J.
Department Of Medical Oncology The Netherlands Cancer Institute/antoni Van Leeuwenhoek Huis
-
Huizing M.
Dept. Of Pharmacy And Pharmacology Slotervaart Hospital The Netherlands Cancer Institute
-
Rosing H.
Department Of Pharmacy & Pharmacology Slotervaart Hospital/the Netherlands Cancer Institute
関連論文
- Bio-analysis of docetaxel and hydroxylated metabolites in human plasma by high-performance liquid chromatography and automated solid-phase extraction
- Influence of Cremophor EL on the quantification of paclitaxel in plasma using high-performance liquid chromatography with solid-phase extraction as sample pretreatment
- High-performance liquid chromatographic procedures for the quantitative determination of paclitaxel (Taxol) in human urine
- Development and validation of a quantitative assay for the measurement of two HIV-fusion inhibitors, enfuvirtide and tifuvirtide, and one metabolite of enfuvirtide (M-20) in human plasma by liquid chromatography-tandem mass spectrometry
- Bioanalysis and preliminary pharmacokinetics of the acridonecarboxamide derivative GF120918 in plasma of mice and humans by ion-pairing reversed-phase high-performance liquid chromatography with fluorescence detection
- Analysis of Ecteinascidin 743, a new potent marine-derived anticancer drug, in human plasma by high-performance liquid chromatography in combination with solid-phase extraction
- Quantification of topotecan and its metabolite N-desmethyltopotecan in human plasma, urine and faeces by high-performance liquid chromatographic methods
- Quantification of paclitaxel metabolites in human plasma by high-performance liquid chromatography
- Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection
- Review on the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and its phase I and phase II metabolites in biological matrices, foodstuff and beverages
- High-performance liquid chromatographic determination of the novel antitumour drug topotecan and topotecan as the total of the lactone plus carboxylate forms, in human plasma
- Development and validation of a liquid chromatography-tandem mass spectrometry assay for the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its metabolite 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in plasma
- A validated assay for the quantitative analysis of vatalanib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry
- Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum using liquid chromatography coupled with tandem mass spectrometry
- High-performance liquid chromatographic determination of the antifungal drug fluconazole in plasma and saliva of human immunodeficiency virus-infected patients
- Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatograph coupled with tandem mass spectrometry
- Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometry
- Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry
- Analytical procedure for the determination of the new antitumour drug N-benzoylstaurosporine and three potential metabolites in human plasma by reversed-phase high-performance liquid chromatography